Show simple item record

dc.contributor.authorBaird, Allison Michelle
dc.contributor.authorParker, David C.
dc.date2022-08-11T08:09:00.000
dc.date.accessioned2022-08-23T16:15:14Z
dc.date.available2022-08-23T16:15:14Z
dc.date.issued1996-09-01
dc.date.submitted2008-07-07
dc.identifier.citationJ Immunol. 1996 Sep 1;157(5):1833-9.
dc.identifier.issn0022-1767 (Print)
dc.identifier.pmid8757299
dc.identifier.urihttp://hdl.handle.net/20.500.14038/34039
dc.description.abstractTo investigate the role of B cells as APCs in acquired tolerance induced by low dose soluble protein Ags, normal and B cell-deficient adult mice were injected i.v. with repeated low doses (10 microgram) of deaggregated OVA, then challenged with OVA in CFA. In animals treated with deaggregated OVA, the in vitro proliferative responses of lymph node T cells to OVA were significantly reduced, and production of the Th1 cytokine, IFN-gamma, in response to OVA was reduced to undetectable levels. This occurred in both normal and B cell-deficient treated animals. B cells were also unnecessary for self tolerance of T cells to the transgenic self Ag, hen egg lysozyme, in a strain with a very low serum lysozyme concentration. Partial low zone tolerance induced by deaggregated, low dose OVA was selective for T cell responses as measured by in vitro proliferation and IL-2 and IFN-gamma production, because Ab responses of B cell-sufficient mice to this T cell-dependent Ag were largely unaffected. Both treated and untreated animals produced equivalent titers of anti-OVA Abs, predominantly of the IgG1 and IgG2b isotypes, following challenge with OVA in CFA.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8757299&dopt=Abstract ">Link to article in PubMed</a>
dc.relation.urlhttp://www.jimmunol.org/content/157/5/1833.long
dc.subjectAnimals; Antibody Formation; Antigen-Presenting Cells; B-Lymphocytes; Dose-Response Relationship, Immunologic; Female; Immune Tolerance; Immunologic Deficiency Syndromes; Injections, Intravenous; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mice, Transgenic; Ovalbumin; Self Tolerance; Solubility; Th1 Cells
dc.subjectLife Sciences
dc.subjectMedicine and Health Sciences
dc.titleAnalysis of low zone tolerance induction in normal and B cell-deficient mice
dc.typeJournal Article
dc.source.journaltitleJournal of immunology (Baltimore, Md. : 1950)
dc.source.volume157
dc.source.issue5
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/gsbs_sp/69
dc.identifier.contextkey543962
html.description.abstract<p>To investigate the role of B cells as APCs in acquired tolerance induced by low dose soluble protein Ags, normal and B cell-deficient adult mice were injected i.v. with repeated low doses (10 microgram) of deaggregated OVA, then challenged with OVA in CFA. In animals treated with deaggregated OVA, the in vitro proliferative responses of lymph node T cells to OVA were significantly reduced, and production of the Th1 cytokine, IFN-gamma, in response to OVA was reduced to undetectable levels. This occurred in both normal and B cell-deficient treated animals. B cells were also unnecessary for self tolerance of T cells to the transgenic self Ag, hen egg lysozyme, in a strain with a very low serum lysozyme concentration. Partial low zone tolerance induced by deaggregated, low dose OVA was selective for T cell responses as measured by in vitro proliferation and IL-2 and IFN-gamma production, because Ab responses of B cell-sufficient mice to this T cell-dependent Ag were largely unaffected. Both treated and untreated animals produced equivalent titers of anti-OVA Abs, predominantly of the IgG1 and IgG2b isotypes, following challenge with OVA in CFA.</p>
dc.identifier.submissionpathgsbs_sp/69
dc.contributor.departmentDepartment of Pathology
dc.contributor.departmentGraduate School of Biomedical Sciences
dc.source.pages1833-9


This item appears in the following Collection(s)

Show simple item record